26366-1-AP

antibody from Proteintech Group

Targeting: F2R CF2R, PAR-1, PAR1, TR

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

26366-1-AP

Provider

Proteintech Group

Product name

F2R antibody

Antibody type

Polyclonal

Description

KD/KO validated F2R antibody (Cat. #26366-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

A Golgi apparatus-related signature predicts the immune microenvironment and prognosis of gastric cancer.

Wu C, Sun L, Zhu W, Huang C, Zhu Z, Liu Z
Genes and immunity 2025 Jun;26(3):242-252

---

POLR1F promotes proliferation and stemness of anaplastic thyroid cancer by activating F2R/p38 MAPK signaling.

Gong Y, Wang S, Fang Z, Hu X, Li Y, Che Y, Tan Z, Su B, Ge M, Pan Z
Biochimica et biophysica acta. Molecular cell research 2025 Jun;1872(5):119963

---

The molecular subtype based on cell cycle-related gene signature predicts the prognosis and chemotherapy and immunotherapy response in gastric cancer.

Su R, Chen J, Dai C, Yin S, Chen H, Sun X, Fang Z, Zhang C, Chen J, Gu L
Scientific reports 2025 Jul 1;15(1):20858

---

Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15.

Liu C, Lan Q, Cao S, Zheng F, Liang Y, Shen J, Wang Y, Ikezoe T, Xu K, Pan B
Leukemia 2024 Jun;38(6):1390-1402

---

Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.

Zhu Y, Tao Z, Chen Y, Lin S, Zhu M, Ji W, Liu X, Li T, Hu X
Breast cancer research and treatment 2022 May;193(1):65-81